Updating ...
Home
About Us
Journal History
Submission Fee
Abstracting And Indexing
Copyright
Digital Archiving and Preservation Policy
Aims and Scope
Editorial Board
Instructions to Authors
Instructions to Authors
Manuscript Preparation
Ethical Policy
Contact Us
EJBH - Study group
Archive
Author Index
Turkish Federation of Breast Diseases Societies
Archive
Author Index
Turkish Federation of Breast Diseases Societies
E-ISSN:2587-0831
Toggle navigation
Home
About Us
Journal History
Submission Fee
Abstracting And Indexing
Copyright
Digital Archiving and Preservation Policy
Aims and Scope
Editorial Board
Instructions to Authors
Instructions to Authors
Manuscript Preparation
Ethical Policy
Contact Us
EJBH - Study group
Review
The Adventure of Axillary Treatment in Early Stage Breast Cancer
Bekir Kuru
Eur J Breast Health 2020; 16: 1-15
DOI: 10.5152/ejbh.2019.5157
Full
Text
PDF
Read
THE INTERACTION OF RADIOTHERAPY AND CHEMOTHERAPY IN BREAST CANCER TREATMENT
Füsun Tokatlı
Eur J Breast Health 2008; 4: 70-76
Full
Text
PDF
Read
Extended Sentinel Node Biopsy in Breast Cancer Patients who Achieve Complete Nodal Response with Neoadjuvant Chemotherapy
Alfredo Carlos Simões Dornellas de Barros
Danúbia Ariana de Andrade
Eur J Breast Health 2020; 16: 99-105
DOI: 10.5152/ejbh.2020.4730
Full
Text
PDF
Read
Treatment Changes in Breast Cancer Management and De-Escalation of Breast Surgery
Tolga Ozmen
Vahit Ozmen
Eur J Breast Health 2023; 19: 186-190
DOI: 10.4274/ejbh.galenos.2023.2023-6-2
PMID:37415650
Full
Text
PDF
Read
Original Article
A Systematic Review and Pooled Analysis of Studies of Oral Etoposide in Metastatic Breast Cancer
Ioannis A. Voutsadakis
Eur J Breast Health 2018; 14: 10-16
DOI: 10.5152/ejbh.2017.3563
Full
Text
PDF
Read
EVALUATİON OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY İN PATİENTS WİTH BREAST CANCER
Can Atalay
Niyazi Karaman
Kerim Bora Yılmaz
Mehmet Altınok
Eur J Breast Health 2007; 3: 26-30
Full
Text
PDF
Read
SCUBE2
as a Marker of Resistance to Taxane-based Neoadjuvant Chemotherapy and a Potential Therapeutic Target in Breast Cancer
Gülnihal Özcan
Eur J Breast Health 2023; 19: 45-54
DOI: 10.4274/ejbh.galenos.2022.2022-8-2
PMID:36605472
Full
Text
PDF
Read
Taste Alteration in Patients Receiving Chemotherapy
Elif Sözeri
Sevinç Kutlutürkan
Eur J Breast Health 2015; 11: 81-87
DOI: 10.5152/tjbh.2015.2489
Full
Text
PDF
Read
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in cN0 Breast Cancer: Impact of HER2-Positive Status on Survival
Juan Alors-Ruiz
Salomé Sanz-Viedma
Francisco Javier Fernández-Garcia
Francisco Sendra-Portero
Eur J Breast Health 2024; 20: 94-101
DOI: 10.4274/ejbh.galenos.2024.2023-11-3
Full
Text
PDF
Read
The Evaluation of a Cost-Effective Method for Tumour Marking Prior to Neo-Adjuvant Chemotherapy Using Silver Rods
Amr Hossam
Adel El-Badrawy
Ashraf Khater
Ahmed Setit
Sameh Roshdy
Khaled Abdelwahab
Emad Hamed
Eur J Breast Health 2023; 19: 99-105
DOI: 10.4274/ejbh.galenos.2022.2022-10-3
PMID:36605477
Full
Text
PDF
Read
Evaluation of Neoadjuvant Chemotherapy Response with Dynamic Contrast Enhanced Breast Magnetic Resonance Imaging in Locally Advanced Invasive Breast Cancer
Naciye Sinem Gezer
Ozge Orbay
Pinar Balcı
Merih Guray Durak
Binnaz Demirkan
Serdar Saydam
Eur J Breast Health 2014; 10: 111-118
DOI: 10.5152/tjbh.2014.2035
Full
Text
PDF
Read
The Correlation of Magee Equations
TM
and Oncotype DX
®
Recurrence Score From Core Needle Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in ER+ and HER2- Breast Cancer
Atilla Soran
Kaori Tane
Efe Sezgin
Rohit Bhargava
Eur J Breast Health 2020; 16: 117-123
DOI: 10.5152/ejbh.2020.5338
Full
Text
PDF
Read
The Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant Chemotherapy
Tuba Kayan Tapan
Filiz Çelebi
Kourosh Yaghouti
Filiz Ağaçayak
Serkan İlgün
Gürsel Soybir
Gül Alço
Naziye Ak
Çetin Ordu
Enver Özkurt
Çağlar Ünal
Sevgi Kurt
Alper Öztürk
Zeynep İyigün
Tomris Duymaz
Vahit Özmen
Eur J Breast Health 2024; 20: 117-121
DOI: 10.4274/ejbh.galenos.2024.2023-12-5
Full
Text
PDF
Read
Comparison of MRI and US in Tumor Size Evaluation of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Onur Taydaş
Gamze Durhan
Meltem Gülsün Akpınar
Figen Başaran Demirkazık
Eur J Breast Health 2019; 15: 119-124
DOI: 10.5152/ejbh.2019.4547
Full
Text
PDF
Read
Clinicopathological Features of Breast Cancer with Polysomy 17 and Its Response to Neoadjuvant Chemotherapy
Hongxia Sun
Hui Chen
James Crespo
Guilin Tang
Melissa Robinson
Bora Lim
Ayşegül A. Şahin
Eur J Breast Health 2021; 17: 128-136
DOI: 10.4274/ejbh.galenos.2021.2021-2-9
PMID:33870112
Full
Text
PDF
Read
Predictors of Unilateral Arm Lymphedema in Non-obese Locoregionally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy, Modified Radical Mastectomy, and Postoperative Irradiation
Surjeet Dwivedi
Amiy Arnav
Varun Kumar Agarwal
S K Deshpande
Rohit Sharma
Naresh Saidha
Eur J Breast Health 2024; 20: 149-155
DOI: 10.4274/ejbh.galenos.2024.2024-1-11
Full
Text
PDF
Read
Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer
Tarik Sengoz
Yeliz Arman Karakaya
Aziz Gültekin
Sevda Yilmaz
Ergun Erdem
Burcu Yapar Taskoylu
Zehra Kesen
Olga Yaylali
Dogangun Yuksel
Eur J Breast Health 2023; 19: 159-165
DOI: 10.4274/ejbh.galenos.2023.2023-1-3
PMID:37025574
Full
Text
PDF
Read
Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer Patients
Özlem Özdemir
Baha Zengel
Demet Kocatepe Çavdar
Cengiz Yılmaz
Raika Durusoy
Eur J Breast Health 2022; 18: 167-171
DOI: 10.4274/ejbh.galenos.2022.2022-1-4
PMID:35445177
Full
Text
PDF
Read
Prognostic Significance of Adjuvant Chemotherapy Induced Amenorrhea in Luminal A and B Subtypes
Çetin Ordu
Kezban Nur Pilancı
Gül Alço
Filiz Elbüken
Ülkühan İner Köksal
Serkan İlgun
Dauren Sarsenov
Ayşe Esra Aydın
Alper Öztürk
Zeynep İyigün Erdoğan
Filiz Ağaçayak
Fatmagül Çubuk
Coşkun Tecimer
Yeşim Eralp
Tomris Duymaz
Fatma Aktepe
Vahit Özmen
Eur J Breast Health 2018; 14: 173-179
DOI: 10.5152/ejbh.2018.3808
Full
Text
PDF
Read
The Effect of Systemic Chemotherapy on Ovarian Function: A Prospective Clinical Trial
Filiz Çelebi
Çetin Ordu
Serkan Ilgün
Alper Öztürk
Zeynep Erdoğan Iyigün
Gül Alço
Tomris Duymaz
Fatma Aktepe
Gürsel Soybir
Bülent Baysal
Vahit Özmen
Eur J Breast Health 2020; 16: 177-182
DOI: 10.5152/ejbh.2020.5114
Full
Text
PDF
Read
Impact of COVID-19 On Breast Cancer Management: A Radiological Prespective from A Tertiary Centre
Anjum Syed
Gangotri Kumari
Aakriti Kapoor
Satish Chaitanya
Prateek Sharda
Mriganki Chaudhary
Ananya Deori
Priyanka Gupta
Nilotpal Choudhary
Shalinee Rao
Bina Ravi
Eur J Breast Health 2021; 17: 180-187
DOI: 10.4274/ejbh.galenos.2021.6379
PMID:33870119
Full
Text
PDF
Read
Breast Cancer in Patients 80 Years-Old and Older
Aaron Bertolo
Christopher Rosso
Ioannis A. Voutsadakis
Eur J Breast Health 2020; 16: 208-212
DOI: 10.5152/ejbh.2020.5659
Full
Text
PDF
Read
Evaluation of Pathologic Complete Response (pCR) to Neoadjuvant Chemotherapy in Iranian Breast Cancer Patients with Estrogen Receptor Positive and HER2 Negative and impact of predicting variables on pCR
Ramesh Omranipour
Roghiyeh Jalili
Adel Yazdankhahkenary
Abdolali Assarian
Mehrzad Mirzania
Bita Eslami
Eur J Breast Health 2020; 16: 213-218
DOI: 10.5152/ejbh.2020.5487
Full
Text
PDF
Read
Inflammatory Markers Predicting Pathological Complete Response in Cases with Breast Cancer Treated by Neoadjuvant Chemotherapy
Mahmut Büyükşimşek
Ali Oğul
Cem Mirili
Semra Paydaş
Eur J Breast Health 2020; 16: 229-234
DOI: 10.5152/ejbh.2020.5556
Full
Text
PDF
Read
Lymph Node Ratio (LNR): Predicting Prognosis after Neoadjuvant Chemotherapy (NAC) in Breast Cancer Patients
Atilla Soran
Tolga Ozmen
Arsalan Salamat
Gürsel Soybir
Ronald Johnson
Eur J Breast Health 2019; 15: 249-255
DOI: 10.5152/ejbh.2019.4848
Full
Text
PDF
Read
Colour Coding Navigation: “Triage” Techniques to Improve Compliance in Breast Cancer Patients Requiring Primary Chemotherapy
Carol Ann Benn
Yastira Ramdas
Barend van den Bergh
Naa-Lamle Bannerman
Dominic van Loggerenberg
Tia van Loggerenberg
Vernon Shaw
Eur J Breast Health 2020; 16: 262-266
DOI: 10.5152/ejbh.2020.5784
Full
Text
PDF
Read
An Overview of the Impact of Body Mass Index on Pathological Complete Response Following Neoadjuvant Chemotherapy in Operable Breast Cancer in a Tertiary Care Centre in South India
SP Somashekhar
Richa Jaiswal
Rohit Kumar
BC Ashok
Susmita Rakshit
Amit Rauthan
Poonam Patil
Nitin Yashas
HK Karthik
Archa Prasad
Herra Islam
KR Ashwin
Eur J Breast Health 2022; 18: 271-278
DOI: 10.4274/ejbh.galenos.2022.2022-2-5
PMID:35855193
Full
Text
PDF
Read
Determination of Self-Efficacy, Body Image and Sexual Adjustment of Women with Breast Cancer
Fatma Arıkan
Öznur Körükçü
Ayşegül Küçükçakal
Hasan Şenol Coşkun
Eur J Breast Health 2020; 16: 282-289
DOI: 10.5152/ejbh.2020.5188
Full
Text
PDF
Read
Is Electrocardiogram Helpful in Predicting a Rise in Troponin I as a Marker of Anthracycline Cardiotoxicity?
Kader Muneer
Benny Jose
Gajendra Dubey
Ajayakumar T
Sajeev CG
Krishnan MN
Eur J Breast Health 2022; 18: 299-305
DOI: 10.4274/ejbh.galenos.2022.2021-9-8
PMID:36248753
Full
Text
PDF
Read
Neo-Adjuvant Chemotherapy in Luminal, Node Positive Breast Cancer: Characteristics, Treatment and Oncological Outcomes: A Single Center’s Experience
Erika Barbieri
Damiano Gentile
Alberto Bottini
Andrea Sagona
Wolfgang Gatzemeier
Agnese Losurdo
Bethania Fernandes
Corrado Tinterri
Eur J Breast Health 2021; 17: 356-362
DOI: 10.4274/ejbh.galenos.2021.2021-4-8
PMID:34651115
Full
Text
PDF
Read
Case Report
CHEST WALL RELAPSE OF DUCTAL CARCINOMA IN SITU AFTER MASTECTOMY: A CASE REPORT
Bektaş Kaya
Bekir Hakan Bakkal
Meral Sayın
Eur J Breast Health 2013; 9: 35-37
Full
Text
PDF
Read
BILATERAL PRIMARY BREAST LYMPHOMA: A RARE CASE
İbrahim Yetim
Tülin Durgun Yetim
Orhan Veli Özkan
Güvenç Diner
Nazan Savaş
Ramazan Davran
Rahmi Helvacı
Hasan Kaya
Eur J Breast Health 2011; 7: 185-187
Full
Text
PDF
Read
Mucormycosis of the Breast in a Patient With Breast Carcinoma After COVID-19 Pneumonia
SP Somashekhar
Richa Jaiswal
Rohit Kumar
BC Ashok
Susmita Rakshit
Amit Rauthan
HK Karthik
Archa Prasad
Herra Islam
Aaron Fernandes
Elroy Saldahana
KR Ashwin
Eur J Breast Health 2022; 18: 289-291
DOI: 10.4274/ejbh.galenos.2022.2022-2-4
PMID:35855194
Full
Text
PDF
Read
Research Article
DOES THE NEOADJUVANT CHEMOTHERAPY REDUCE THE NUMBER OF AXILLARY LYMPH NODES REMOVED IN PATIENTS WITH BREAST CANCER?
Kaptan Gülben
Uğur Berberoğlu
Eur J Breast Health 2010; 6: 118-121
Full
Text
PDF
Read
Original Articles
AXILLARY RESPONSE TO NEO-ADJUVAN CHEMOTHERAPY: DECREASE IN NUMBER OF LYMPH NODES
Erol Aksaz
Tayanç Oncel
Turay Yazıcı
Adil Aydemir
Sibel Bayer
Nuray İpek
Eur J Breast Health 2012; 8: 134-137
Full
Text
PDF
Read
PROFILES AND PREDICTIVE FACTORS IN YOUNG AGE BREAST CANCER PATIENTS (RETROSPECTIVE STUDY)
Erol Aksaz
Güven Atasoy
Tayanç Öncel
Turay Yazıcı
Adil Aydemir
Nuray İpek
Dilek Bitik
Eur J Breast Health 2012; 8: 175-179
Full
Text
PDF
Read
EVALUATION OF THE EFFECT OF EDUCATION OF CHEMOTHERAPY SIDE EFFECTS AND HOME FOLLOW-UP ON THE QUALITY OF LIFE IN PATIENTS WITH BREAST CANCER GIVEN CHEMOTHERAPY
Duygu Akçay
Sebahat Gözüm
Eur J Breast Health 2012; 8: 191-199
Full
Text
PDF
Read
1
2
»
Advanced Search
About Journal
Article Tools
Subscribe
×
×
Subscribe
Full Name
E-mail